High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats
Autor: | Virginia Rodriguez-Menendez, Elisa Ballarini, Marina Quartu, Chiara Briani, Annalisa Canta, Guido Cavaletti, Norberto Oggioni, Valentina Alda Carozzi, Paola Marmiroli, G Fumagalli, Alessia Chiorazzi, C Scali, Nadia Spinoni, Cristina Galliani, Laura Monza, Cristina Meregalli, Eleonora Pozzi, Paola Alberti, I Marjanovic, Rinaldo Brivio |
---|---|
Přispěvatelé: | Meregalli, C, Marjanovic, I, Scali, C, Monza, L, Spinoni, N, Galliani, C, Brivio, R, Chiorazzi, A, Ballarini, E, Rodriguez-Menendez, V, Carozzi, V, Alberti, P, Fumagalli, G, Pozzi, E, Canta, A, Quartu, M, Briani, C, Oggioni, N, Marmiroli, P, Cavaletti, G |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Neurology Hot Temperature Human intravenous immunoglobulin (IVIG) Neural Conduction Pharmacology lcsh:RC346-429 Bortezomib 0302 clinical medicine Nerve Fibers Neuroinflammation hemic and lymphatic diseases Medicine Skin General Neuroscience Peripheral Allodynia Neutrophil Infiltration Hyperalgesia Sensory Thresholds Neuropathic pain Cytokines Neurotoxicity Syndromes medicine.symptom medicine.drug medicine.medical_specialty Immunology Immunoglobulins Antineoplastic Agents 03 medical and health sciences Cellular and Molecular Neuroscience Peripheral neurotoxicity Neuroscience (all) Bortezomib Peripheral neurotoxicity Allodynia Human intravenous immunoglobulin (IVIG) Neuroinflammation Physical Stimulation Animals Immunologic Factors Peripheral Nerves Adverse effect lcsh:Neurology. Diseases of the nervous system business.industry Macrophages Research Body Weight Neurotoxicity medicine.disease Rats Disease Models Animal 030104 developmental biology business 030217 neurology & neurosurgery |
Zdroj: | Journal of Neuroinflammation Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-12 (2018) |
ISSN: | 1742-2094 |
Popis: | Background Chemotherapy-induced peripheral neurotoxicity (CIPN) is a severe adverse effect in patients receiving antitumor agents, and no effective treatment is available. Although the mechanisms responsible for the development of CIPN are poorly understood, recent findings make neuroinflammation an attractive target to be investigated, particularly when neuropathic pain is a prominent feature such as after bortezomib administration. The aim of our study was to evaluate the effect of intravenous immunoglobulins (IVIg) delivery in chronic CIPN. The related neuro-immune aspects were investigated in a well-characterized rat model of bortezomib-induced peripheral neurotoxicity (BIPN). Methods After determination of a suitable schedule based on a preliminary pharmacokinetic pilot study, female Wistar rats were treated with IVIg 1 g/kg every 2 weeks. IVIg treatment was started at the beginning of bortezomib administration (“preventive” schedule), or once BIPN was already ensued after 4 weeks of treatment (“therapeutic” schedule). Neurophysiological and behavioral studies were performed to assess the extent of painful peripheral neurotoxicity induced by bortezomib, and these functional assessments were completed by pathologic examination of peripheral nerves and intraepidermal nerve fiber quantification (IENF). The role of the innate immune response in BIPN was investigated by immunochemistry characterization of macrophage infiltration in peripheral nerves. Results Both schedules of IVIg administration were able to significantly reduce bortezomib-induced heat and mechanical allodynia. Although these changes were not evidenced at the neurophysiological examination of peripheral nerves, they behavioral effects were paralleled in the animals treated with the preventive schedule by reduced axonopathy in peripheral nerves and significant protection from loss of IENF. Moreover, IVIg administration was very effective in reducing infiltration in peripheral nerves of macrophages with the M1, pro-inflammatory phenotype. Conclusion Our results suggest a prominent role of neuroinflammation in BIPN and that IVIg might be considered as a possible safe and effective therapeutic option preventing M1 macrophage infiltration. However, since neuropathic pain is frequent also in other CIPN types, it also indicates the need for further investigation in other forms of CIPN. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |